Based on the decisions you recommended for the patient case study, explain whether you believe the decisions provided were supported by the evidence-based literature.

COURSE: ADVANCED PHARMACOLOGY
ASSIGNMENT

Decision Tree for Neurological and Musculoskeletal Disorder

• Capture every numbered question on the rubrics maintaining subtitles pls Apa 7th edition,. Use 2 -4 articles from course resource and another 3 -4 articles from outside resource less than 5 yrs.

Module 5: Neurologic and Musculoskeletal Systems and
Opioids
Assignment Topic: Week 6: Decision Tree for

Neurological and Musculoskeletal Disorders For your Assignment, your Instructor will assign you one of the decision tree interactive media pieces provided in the Resources. As you examine the patient case studies in this module’s Resources, consider how you might assess and treat patients presenting symptoms of neurological and musculoskeletal disorders.

To Prepare

• Review the interactive media piece assigned by your Instructor.

• Reflect on the patient’s symptoms and aspects of the disorder presented in the interactive media piece.

• Consider how you might assess and treat patients presenting with the symptoms of the patient case study you were assigned.

• You will be asked to make three decisions concerning the diagnosis and treatment for this patient. Reflect on potential co-morbid physical as well as patient factors that might impact the patient’s diagnosis and treatment.

 

 

Write a 1- to 2-page summary paper that addresses the following:

• Briefly summarize the patient case study you were assigned, including each of the three decisions you took for the patient presented.

• Based on the decisions you recommended for the patient case study, explain whether you believe the decisions provided were supported by the evidence-based literature.

Be specific and provide examples. Be sure to support your response with evidence and references from outside resources.

• What were you hoping to achieve with the decisions you recommended for the patient case study you were assigned? Support your response with evidence and references from outside resources.

• Explain any difference between what you expected to achieve with each of the decisions and the results of the decision in the exercise. Describe whether they were different. Be specific and provide examples.

Learning Resources Required Readings

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
• Chapter 11, “Basic Principles of Neuropharmacology” (pp. 67–71)
• Chapter 12, “Physiology of the Peripheral Nervous System” (pp. 72–81)
• Chapter 12, “Muscarinic Agonists and Cholinesterase Inhibitors” (pp. 82–89)
• Chapter 14, “Muscarinic Antagonists” (pp. 90-98)
• Chapter 15, “Adrenergic Agonists” (pp. 99–107)
• Chapter 16, “Adrenergic Antagonists” (pp. 108–119)
• Chapter 17, “Indirect-Acting Antiadrenergic Agents” (pp. 120–124)
• Chapter 18, “Introduction to Central Nervous System Pharmacology” (pp. 125–126)
• Chapter 19, “Drugs for Parkinson Disease” (pp. 127–142)
• Chapter 20, “Drugs for Alzheimer Disease” (pp. 159–166)
• Chapter 21, “Drugs for Seizure Disorders” (pp. 150–170)
• Chapter 22, “Drugs for Muscle Spasm and Spasticity” (pp. 171–178)
• Chapter 24, “Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics” (pp. 183–194)
• Chapter 59, “Drug Therapy of Rheumatoid Arthritis” (pp. 513–527)
• Chapter 60, “Drug Therapy of Gout” (pp. 528–536)
• Chapter 61, “Drugs Affecting Calcium Levels and Bone Mineralization” (pp. 537–556)

American Academy of Family Physicians. (2019). Dementia. Retrieved from
http://www.aafp.org/afp/topicModules/viewTopicModule.htm?topicModuleId=5

This website provides information relating to the diagnosis, treatment, and patient education of dementia. It also presents information on complications and special cases of dementia.

Linn, B. S., Mahvan, T., Smith, B. E. Y., Oung, A. B., Aschenbrenner, H., & Berg, J. M. (2020).

Tips and tools for safe opioid prescribing:

This review–with tables summarizing opioid options, dosing considerations, and recommendations for tapering–will help you provide rigorous Tx for noncancer pain while ensuring patient safety. Journal of Family Practice, 69(6), 280–292.

Required Media (click to expand/reduce)

Laureate Education (Producer). (2019b). Alzheimer’s disease [Interactive media file]. Baltimore,
MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat Alzheimer’s disease.

Laureate Education (Producer). (2019e). Complex regional pain disorder [Interactive media file]. Baltimore, MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat complex regional pain disorders.

Disorders of The Nervous System Reflect on the comprehensive review of disorders of the nervous system and think about how you might recommend or prescribe pharmacotherapeutics to treat these disorders. (15m)
Accessible player –Downloads–Download Video w/CCDownload AudioDownload Transcript

Speed Pharmacology. (2019). Drugs for Parkinson’s Disease (Made Easy) [Video].

Note: This media program is approximately 9 minutes.

Speed Pharmacology. (2019). Pharmacology- Drugs for Alzheimer’s Disease (Made Easy)
[Video]. https://www.youtube.com/watch?v=euzRPrvrwj0&t=31s
Note: This media program is approximately 7 minutes.

Last Completed Projects